Skip to main content
SpringerLink
Log in

Neuromuscular Disease in the ICU

  • Chapter
  • First Online:
Evidence-Based Critical Care

  • 296 Accesses

Abstract

Assessing where a patient is along the spectrum of neuromuscular respiratory failure requires knowledge of respiratory physiology and pathophysiology, the evolution of clinical features, and knowledge of how to interpret diagnostic studies in the context of their limitations. Ultimately, this information can be employed to discern or predict the need for ICU admission and ventilatory support. Of equal importance is a thorough understanding of the most common causes of neuromuscular respiratory failure, how to diagnose them, and their associated complications and treatments. This chapter informs the reader how to approach and manage the patient with limb, bulbar, and respiratory weakness and equips them with the tools to diagnose and treat the most common causes of primary and secondary neuromuscular weakness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wijdicks EFM. The neurology of acutely failing respiratory mechanics. Ann Neurol. 2017;81:485–94.

    PubMed  Google Scholar 

  2. Wijdicks EFM. Management of acute neuromuscular disorders. Handb Clin Neurol. 2017;140(3):229–37.

    CAS  PubMed  Google Scholar 

  3. Greene-Chandos D, Torbey M. Critical care of neuromuscular disorders. Continuum. 2018;24(6):1753–75.

    PubMed  Google Scholar 

  4. Howard RS. Respiratory failure because of neuromuscular disease. Curr Opin Neurol. 2016;29(5):592–601.

    PubMed  Google Scholar 

  5. Irfan M, Selim B, Rabinstein AA, St. Louis EK. Neuromuscular disorders and sleep in critically ill patients. Crit Care Clin. 2015;31(3):533–50.

    PubMed  PubMed Central  Google Scholar 

  6. Cabrera Serrano M, Rabinstein AA. Usefulness of pulmonary function tests and blood gases in acute neuromuscular respiratory failure. Eur J Neurol. 2012;19(3):452–6.

    CAS  PubMed  Google Scholar 

  7. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch Neurol. 2001;58(6):893–8.

    CAS  PubMed  Google Scholar 

  8. Walterspacher S, Kirchberger A, Lambeck J, et al. Respiratory muscle assessment in acute Guillain-Barre syndrome. Lung. 2016;194:821–8.

    CAS  PubMed  Google Scholar 

  9. Kramer CL, McCullough M, Wijdicks EF. Teaching video neuroimages: how to unmask respiratory strength confounded by facial diplegia. Neurology. 2015;84:e57–8.

    PubMed  Google Scholar 

  10. Boon AJ, O’Gorman C. Ultrasound in the assessment of respiration. J Clin Neurophysiol. 2016;33:112–9.

    PubMed  Google Scholar 

  11. Caulfield AF, Flower O, Pineda JA, Uddin S. Emergency neurological life support: acute non-traumatic weakness. Neurocrit Care. 2017;27(Suppl 1):29–50. https://doi.org/10.1007/s12028-017-0450-3.

    Article  PubMed  Google Scholar 

  12. Walgaard C, Lingsma HF, van Doorn PA, et al. Tracheostomy or not: prediction of prolonged mechanical ventilation in Guillain-Barre syndrome. Neurocrit Care. 2017;26:6–13.

    PubMed  Google Scholar 

  13. Lawn ND, Wijdicks EF. Post-intubation pulmonary function test in Guillain-Barre syndrome. Muscle Nerve. 2000;23:613–6.

    CAS  PubMed  Google Scholar 

  14. Cabrera Serrano M, Rabinstein AA. Causes and outcomes of acute neuromuscular respiratory failure. Arch Neurol. 2010;67(9):1089–94.

    PubMed  Google Scholar 

  15. Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366:2294–304.

    CAS  PubMed  Google Scholar 

  16. Dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and the Guillain-Barre syndrome - case series from seven countries. N Engl J Med. 2016;375:1598–601.

    PubMed  Google Scholar 

  17. Gold CA, Josephson SA. Anticipating the challenges of Zika virus and the incidence of Guillain-Barre syndrome. JAMA Neurol. 2016;73:905–6.

    PubMed  Google Scholar 

  18. van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–82.

    PubMed  Google Scholar 

  19. Walgaard C, Lingsma HF, Ruts L, et al. Prediction of respiratory insufficiency in Guillain-Barre syndrome. Ann Neurol. 2010;67:781–7.

    PubMed  Google Scholar 

  20. Zaeem Z, Siddiqi ZA, Zochodne DW. Autonomic involvement in Guillain-Barre syndrome: an update. Clin Auton Res. 2018;29(3):289–99.

    PubMed  Google Scholar 

  21. Vucic S, Cairns KD, Black KR, Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clin Neurophysiol. 2004;115:2329–35.

    PubMed  Google Scholar 

  22. Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N. Conduction block in acute motor axonal neuropathy. Brain. 2010;133:2897–908.

    PubMed  Google Scholar 

  23. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;(7):CD002063.

    Google Scholar 

  24. Raphael JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2012;(2):CD001798.

    Google Scholar 

  25. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2014;137:33–43.

    PubMed  Google Scholar 

  26. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013;80:1650–4.

    PubMed  Google Scholar 

  27. Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC. Early recognition of poor prognosis in Guillain-Barre syndrome. Neurology. 2011;76:968–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Drachman DB. Myasthenia Gravis. Semin Neurol. 2016;36:419–24.

    PubMed  Google Scholar 

  29. Nicolle MW. Myasthenia Gravis and Lambert-Eaton Myasthenic syndrome. Continuum (Minneap Minn). 2016;22:1978–2005.

    Google Scholar 

  30. Skeie GO, Apostolski S, Evoli A, et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2010;17:893–902.

    CAS  PubMed  Google Scholar 

  31. Gilchrist JM, Massey JM, Sanders DB. Single fiber EMG and repetitive stimulation of the same muscle in myasthenia gravis. Muscle Nerve. 1994;17:171–5.

    CAS  PubMed  Google Scholar 

  32. Gajdos P, Chevret S, Toyka KV. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012;12:CD002277.

    PubMed  Google Scholar 

  33. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group. Ann Neurol. 1997;41:789–96.

    CAS  PubMed  Google Scholar 

  34. Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A. Comparative analysis of therapeutic options used for myasthenia gravis. Ann Neurol. 2010;68:797–805.

    PubMed  Google Scholar 

  35. Iorio R, Damato V, Alboini PE, Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol. 2015;262:1115–9.

    CAS  PubMed  Google Scholar 

  36. Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA. Noninvasive ventilation in myasthenic crisis. Arch Neurol. 2008;65:54–8.

    PubMed  Google Scholar 

  37. Seneviratne J, Mandrekar J, Wijdicks EF, Rabinstein AA. Predictors of extubation failure in myasthenic crisis. Arch Neurol. 2008;65:929–33.

    PubMed  Google Scholar 

  38. Rabinstein AA, Mueller-Kronast N. Risk of extubation failure in patients with myasthenic crisis. Neurocrit Care. 2005;3:213–5.

    PubMed  Google Scholar 

  39. Kalita J, Kohat AK, Misra UK. Predictors of outcome of myasthenic crisis. Neurol Sci. 2014;35:1109–14.

    CAS  PubMed  Google Scholar 

  40. Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19:274.

    PubMed  PubMed Central  Google Scholar 

  41. Jolley SE, Bunnell AE, Hough CL. ICU-acquired weakness. Chest. 2016;150:1129–40.

    PubMed  PubMed Central  Google Scholar 

  42. Kress JP, Hall JB. ICU-acquired weakness and recovery from critical illness. N Engl J Med. 2014;370:1626–35.

    CAS  PubMed  Google Scholar 

  43. Kramer CL. ICU-acquired weakness. Neurol Clin. 2017;35(4):723–36. https://doi.org/10.1016/j.ncl.2017.06.008.

    Article  PubMed  Google Scholar 

  44. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013;187:238–46.

    PubMed  Google Scholar 

  45. Jung B, Moury PH, Mahul M, et al. Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med. 2016;42:853–61.

    PubMed  Google Scholar 

  46. Kramer CL, Boon AJ, Harper CM, Goodman BP. Compound muscle action potential duration in critical illness neuromyopathy. Muscle Nerve. 2018;57(3):395–400. https://doi.org/10.1002/mus.25732.

    Article  PubMed  Google Scholar 

  47. Hermans G, De Jonghe B, Bruyninckx F, Van den Berghe G. Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev. 2014:CD006832.

    Google Scholar 

  48. Kayambu G, Boots R, Paratz J. Physical therapy for the critically ill in the ICU: a systematic review and meta-analysis. Crit Care Med. 2013;41:1543–54.

    PubMed  Google Scholar 

  49. Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009;37:2499–505.

    PubMed  Google Scholar 

  50. Kho ME, Truong AD, Zanni JM, et al. Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015;30:32–9.

    PubMed  Google Scholar 

  51. Jones S, Man WD, Gao W, Higginson IJ, Wilcock A, Maddocks M. Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease. Cochrane Database Syst Rev. 2016;10:CD009419.

    PubMed  Google Scholar 

  52. Hermans G, Van Mechelen H, Clerckx B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190:410–20.

    PubMed  Google Scholar 

  53. Sharshar T, Bastuji-Garin S, Stevens RD, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med. 2009;37:3047–53.

    PubMed  Google Scholar 

  54. Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196.

    PubMed  PubMed Central  Google Scholar 

  55. Harvey MA, Davidson JE. Postintensive care syndrome: right care, right now…and later. Crit Care Med. 2016;44:381–5.

    PubMed  Google Scholar 

  56. Sacanella E, Perez-Castejon JM, Nicolas JM, et al. Functional status and quality of life 12 months after discharge from a medical ICU in healthy elderly patients: a prospective observational study. Crit Care. 2011;15:R105.

    PubMed  PubMed Central  Google Scholar 

  57. Guarneri B, Bertolini G, Latronico N. Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry. 2008;79:838–41.

    CAS  PubMed  Google Scholar 

  58. Rabinstein AA. Noninvasive ventilation for neuromuscular respiratory failure: when to use and when to avoid. Curr Opin Crit Care. 2016;22(2):94–9.

    PubMed  Google Scholar 

  59. Wijdicks EF, Henderson RD, McClelland RL. Emergency intubation for respiratory failure in Guillain-Barre syndrome. Arch Neurol. 2003;60:947–8.

    PubMed  Google Scholar 

  60. Wijdicks EF, Roy TK. BiPAP in early Guillain-Barre syndrome may fail. Can J Neurol Sci. 2006;33:105–6.

    PubMed  Google Scholar 

  61. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet. 1997;349:225–30.

    Google Scholar 

  62. van Koningsveld R, Schmitz PI, Meche FG, et al. Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barre syndrome: randomised trial. Lancet. 2004;363:192–6.

    PubMed  Google Scholar 

  63. Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V. Comparison of IVIg and PLEX in patients with myasthenia gravis. Neurology. 2011;76:2017–23.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Chicago, Chicago, IL, USA

    Christopher L. Kramer

  2. Mayo Clinic, Rochester, MN, USA

    Alejandro A. Rabinstein

Authors
  1. Christopher L. Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alejandro A. Rabinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alejandro A. Rabinstein .

Editor information

Editors and Affiliations

  1. Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA

    Robert C. Hyzy

  2. Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI, USA

    Jakob McSparron

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kramer, C.L., Rabinstein, A.A. (2020). Neuromuscular Disease in the ICU. In: Hyzy, R.C., McSparron, J. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-26710-0_44

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26710-0_44

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26709-4

  • Online ISBN: 978-3-030-26710-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation